共 49 条
- [1] D'Amico G, Garcia-Tsao G, Pagliaro L., Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies, J Hepatol, 44, pp. 217-231, (2006)
- [2] Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R., Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, pp. 646-649, (1973)
- [3] Kamath PS, Wiesner RH, Malinchoc M, Et al., A model to predict survival in patients with end-stage liver disease, Hepatology, 33, pp. 464-470, (2001)
- [4] Kamath PS, Kim WR, The model for end-stage liver disease (MELD), Hepatology, 45, pp. 797-805, (2007)
- [5] Cholongitas E, Senzolo M, Triantos C, Samonakis D, Patch D, Burroughs AK., MELD is not enough--enough of MELD?, J Hepatol, 42, pp. 475-479, (2005)
- [6] Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK., Systematic review: The model for end-stage liver disease--should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis?, Aliment Pharmacol Ther, 22, pp. 1079-1089, (2005)
- [7] Bernardi M, Gitto S, Biselli M., The MELD score in patients awaiting liver transplant: strengths and weaknesses, J Hepatol, 54, pp. 1297-1306, (2011)
- [8] Johnson PJ, Berhane S, Kagebayashi C, Et al., Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade, J Clin Oncol, 33, pp. 550-558, (2015)
- [9] Toyoda H, Lai PBS, O'Beirne J, Et al., Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade, Br J Cancer, 114, pp. 744-750, (2016)
- [10] Hiraoka A, Kumada T, Michitaka K, Et al., Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma, J Gastroenterol Hepatol, 31, pp. 1031-1036, (2016)